Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2023
  2. Published

    Precision Medicine and/or Biomarker Based Therapy in T2DM: Ready for Prime Time?

    Rossing, Peter, Frimodt-Møller, M. & Persson, F., 2023, In: Seminars in Nephrology. 43, 3, 151430.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial

    on the behalf of the PRIORITY Study Group, O. T. B. O. T. P. S. G., 2023, In: Journal of Diabetes and its Complications. 37, 4, 7 p., 108433.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study

    Jaimes Campos, M. A., Andújar, I., Keller, F., Mayer, G., Rossing, P., Staessen, J. A., Delles, C., Beige, J., Glorieux, G., Clark, A. L., Mullen, W., Schanstra, J. P., Vlahou, A., Rossing, K., Peter, K., Ortiz, A., Campbell, A., Persson, F., Latosinska, A., Mischak, H. & 2 others, Siwy, J. & Jankowski, J., 2023, In: Pharmaceuticals. 16, 9, 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Prognostic value of myocardial performance index in individuals with type 1 and type 2 diabetes: Thousand&1 and Thousand&2 studies

    Bahrami, H. S. Z., Jørgensen, P. G., Hove, Jens Dahlgaard, Dixen, Ulrik, Biering-Sørensen, Tor, Rossing, Peter & Jensen, M. T., 2023, In: European Heart Journal Cardiovascular Imaging. 24, 11, p. 1555-1562 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Rationale and design of a prospective, clinical study of kidney biopsies in people with type 2 diabetes and severely increased albuminuria (the PRIMETIME 2 study)

    Møller, M., Borg, Rikke, Bressendorff, I., Fink, L. N., Gravesen, E., Jensen, K. H., Hansen, Torben, Krustrup, D., Persson, F., Rossing, Peter, Sembach, F. E., Thuesen, Anne Cathrine Baun & Hansen, Ditte, 2023, In: BMJ Open. 13, 6, e072216.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

    Heerspink, H. J. L., Birkenfeld, A. L., Cherney, D. Z. I., Colhoun, H. M., Ji, L., Mathieu, C., Groop, P. H., Pratley, R. E., Rosas, S. E., Rossing, Peter, Skyler, J. S., Tuttle, K. R., Lawatscheck, R., Scott, C., Edfors, R., Scheerer, M. F., Kolkhof, P. & McGill, J. B., 2023, In: Diabetes Research and Clinical Practice. 204, 17 p., 110908.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes

    Khurana, I., Kaipananickal, H., Maxwell, S., Birkelund, S., Syreeni, A., Forsblom, C., Okabe, J., Ziemann, M., Kaspi, A., Rafehi, H., Jørgensen, A., Al-Hasani, K., Thomas, M. C., Jiang, G., Luk, A. O. Y., Lee, H. M., Huang, Y., Thewjitcharoen, Y., Nakasatien, S., Himathongkam, T. & 12 others, Fogarty, C., Njeim, R., Eid, A., Hansen, T. W., Tofte, N., Ottesen, E. C., Ma, R. C. W., Chan, J. C. N., Cooper, M. E., Rossing, Peter, Groop, P. H. & El-Osta, A., 2023, In: Journal of Clinical Investigation. 133, 4, e160959.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial

    Brandt-Jacobsen, N. H., Jurgens, M., Hasbak, P., Gaede, P., Rossing, Peter, Rasmussen, J. J., Andersen, C. F., Forman, Julie Lyng, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2023, In: Diabetes, Obesity and Metabolism. 25, 3, p. 844-855 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes

    Stougaard, E. B., Rossing, Peter, Vistisen, D., Banks, P., Girard, M., Davies, M. J. & Persson, F., 2023, In: Diabetes, Obesity and Metabolism. 25, 7, p. 1874-1882 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis

    Thiele, M., Suvitaival, T., Trošt, K., Kim, M., de Zawadzki, A., Kjaergaard, M., Rasmussen, D. N., Lindvig, K. P., Israelsen, M., Detlefsen, S., Andersen, P., Juel, H. B., Nielsen, T., Georgiou, S., Filippa, V., Kuhn, M., Nishijima, S., Moitinho-Silva, L., Rossing, P., Trebicka, J. & 14 others, Anastasiadou, E., Bork, P., Hansen, T., Legido-Quigley, C., Krag, A., Mann, M., Matthijnssens, J., Arumugam, Mani, Henrar, R., Israelsen, H., Karsdal, M., Melberg, H. O., MicrobLiver Consortium, M. C. & GALAXY Consortium, G. C., 2023, In: Gastroenterology. 164, 7, p. 1248-1260

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...3 4 5 6 7 8 Next

ID: 12937790